290 related articles for article (PubMed ID: 17449149)
1. Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
Alonso JM; Gilmet G; Rouzic EM; Nassif X; Plotkin SA; Ramsay M; Siegrist CA; Stephens DS; Teyssou R; Vogel U
Vaccine; 2007 May; 25(21):4125-9. PubMed ID: 17449149
[TBL] [Abstract][Full Text] [Related]
2. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
Harrison LH; Shutt KA; Schmink SE; Marsh JW; Harcourt BH; Wang X; Whitney AM; Stephens DS; Cohn AA; Messonnier NE; Mayer LW
J Infect Dis; 2010 Apr; 201(8):1208-24. PubMed ID: 20199241
[TBL] [Abstract][Full Text] [Related]
3. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal vaccines: Current state and future outlook.
Leca M; Bornet C; Montana M; Curti C; Vanelle P
Pathol Biol (Paris); 2015 Jun; 63(3):144-51. PubMed ID: 25986879
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal vaccination in pregnancy.
Abu Raya B; Sadarangani M
Hum Vaccin Immunother; 2018 May; 14(5):1188-1196. PubMed ID: 29485347
[TBL] [Abstract][Full Text] [Related]
6. Capsule switching of Neisseria meningitidis sequence type 7 serogroup A to serogroup X.
Ji X; Yao PP; Zhang LY; Li Y; Xu F; Mei LL; Zhu SR; Zhang YJ; Zhu HP; van der Veen S
J Infect; 2017 Dec; 75(6):521-531. PubMed ID: 28916450
[TBL] [Abstract][Full Text] [Related]
7. Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.
Dretler AW; Rouphael NG; Stephens DS
Hum Vaccin Immunother; 2018 May; 14(5):1146-1160. PubMed ID: 29543582
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of anti-idiotype based peptide and DNA vaccines which mimic the capsular polysaccharide of Neisseria meningitidis serogroup C.
Westerink MA; Smithson SL; Hutchins WA; Widera G
Int Rev Immunol; 2001; 20(2):251-61. PubMed ID: 11878768
[TBL] [Abstract][Full Text] [Related]
9. Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.
Bechini A; Levi M; Boccalini S; Tiscione E; Ceccherini V; Taddei C; Balocchini E; Bonanni P
J Prev Med Hyg; 2012 Jun; 53(2):61-7. PubMed ID: 23240162
[TBL] [Abstract][Full Text] [Related]
10. Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A.
Zhu B; Yao P; Zhang L; Gao Y; Xu L; Xie N; Shao Z
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28320835
[No Abstract] [Full Text] [Related]
11. Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients.
Wyplosz B; Derradji O; Hong E; François H; Durrbach A; Duclos-Vallée JC; Samuel D; Escaut L; Launay O; Vittecoq D; Taha MK
Transpl Infect Dis; 2015 Apr; 17(2):322-7. PubMed ID: 25645691
[TBL] [Abstract][Full Text] [Related]
12. No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales.
Trotter CL; Ramsay ME; Gray S; Fox A; Kaczmarski E
Lancet Infect Dis; 2006 Oct; 6(10):616-7; author reply 617-8. PubMed ID: 17008169
[No Abstract] [Full Text] [Related]
13. Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
Vu DM; Welsch JA; Zuno-Mitchell P; Dela Cruz JV; Granoff DM
J Infect Dis; 2006 Mar; 193(6):821-8. PubMed ID: 16479517
[TBL] [Abstract][Full Text] [Related]
14. Fighting Neisseria meningitidis: past and current vaccination strategies.
Piccini G; Torelli A; Gianchecchi E; Piccirella S; Montomoli E
Expert Rev Vaccines; 2016 Nov; 15(11):1393-1407. PubMed ID: 27158988
[TBL] [Abstract][Full Text] [Related]
15. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
[TBL] [Abstract][Full Text] [Related]
16. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches to Neisseria meningitidis vaccine design.
Christodoulides M; Heckels J
Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28369428
[TBL] [Abstract][Full Text] [Related]
19. Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
Nunes AM; Ribeiro GS; Ferreira ÍE; Moura AR; Felzemburgh RD; de Lemos AP; Reis MG; de Moraes JC; Campos LC
PLoS One; 2016; 11(11):e0166475. PubMed ID: 27861618
[TBL] [Abstract][Full Text] [Related]
20. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines.
Diggle MA; Clarke SC
J Clin Microbiol; 2005 Sep; 43(9):4649-53. PubMed ID: 16145121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
